you are here: Home News Zydus

Zydus

Delhi High Court allows Zydus to sell cheaper biosimilar of cancer drug Nivolumab in public interest
Zydus enters biologics CDMO with acquisitions valued at $125 million
Nifty Pharma settles 2% higher on exclusion from Trump's reciprocal tariffs; Lupin, IPCA Labs up 5%
Indian pharma players can deliver 100 new drugs by 2047: Zydus Chairman
Trump Tariff – How much can it hurt Indian pharma?
Stocks on Radar | Mankind Pharma, Zydus Lifesciences, Ashoka Buildcon, Hero Motocorp in Focus
Zydus Lifesciences to buy Perfect Day's 50% stake in Sterling Biotech to forge a 50:50 JV
Zydus gets Mexican regulatory approval to market cancer treatment product
Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain in heart patients
Zydus launches pill for prostate cancer patients
Zydus gets USFDA nod for generic medication for postherpetic neuralgia
Zydus Life subsidiary gets Income Tax demand of Rs 280 cr
Zydus gets USFDA nod for antiviral drug used in HIV treatment
Zydus receives final approval from USFDA for Methylene Blue Injection
Zydus Lifesciences: Why we are getting constructive
Lupin, Zydus Lifesciences ink licensing and supply pact for Saroglitazar Mg
Zydus Life to acquire LiqMeds Group for Rs 689 crore
Zydus, Sun Pharma to co-market oral drug for anaemia linked to kidney diseases
Moneycontrol Selects: Top stories this evening
Zydus Lifesciences: Time to book profit, post strong rally over a year?
Delhi HC bars Zydus Wellness from using ‘SugarLite’ brand name
Zydus recalls over 55,000 bottles of generic drug in US
Zydus Lifesciences gets USFDA nod to market generic drug to lower cholesterol levels
Zydus, Medtronic partner for first AI-based stroke care network in Gujarat
Zydus, Baba Ramdev firm among 16 barred from selling drugs in Nepal

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Zydus

Delhi High Court allows Zydus to sell cheaper biosimilar of cancer drug Nivolumab in public interest

Zydus enters biologics CDMO with acquisitions valued at $125 million

Nifty Pharma settles 2% higher on exclusion from Trump's reciprocal tariffs; Lupin, IPCA Labs up 5%

Indian pharma players can deliver 100 new drugs by 2047: Zydus Chairman

Trump Tariff – How much can it hurt Indian pharma?

Stocks on Radar | Mankind Pharma, Zydus Lifesciences, Ashoka Buildcon, Hero Motocorp in Focus

Zydus Lifesciences to buy Perfect Day's 50% stake in Sterling Biotech to forge a 50:50 JV

Zydus gets Mexican regulatory approval to market cancer treatment product

Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain in heart patients

Zydus launches pill for prostate cancer patients

Zydus gets USFDA nod for generic medication for postherpetic neuralgia

Zydus Life subsidiary gets Income Tax demand of Rs 280 cr

Zydus gets USFDA nod for antiviral drug used in HIV treatment

Zydus receives final approval from USFDA for Methylene Blue Injection

Zydus Lifesciences: Why we are getting constructive

Lupin, Zydus Lifesciences ink licensing and supply pact for Saroglitazar Mg

Zydus Life to acquire LiqMeds Group for Rs 689 crore

Zydus, Sun Pharma to co-market oral drug for anaemia linked to kidney diseases

Moneycontrol Selects: Top stories this evening

Zydus Lifesciences: Time to book profit, post strong rally over a year?

Delhi HC bars Zydus Wellness from using ‘SugarLite’ brand name

Zydus recalls over 55,000 bottles of generic drug in US

Zydus Lifesciences gets USFDA nod to market generic drug to lower cholesterol levels

Zydus, Medtronic partner for first AI-based stroke care network in Gujarat

Zydus, Baba Ramdev firm among 16 barred from selling drugs in Nepal